Henry Meds vs Ozari: A Doctor's Honest Comparison of Pricing, Access, and Support

If you've been researching GLP-1 medications like Semaglutide or Tirzepatide for weight loss, you've probably come across both Henry Meds and Ozari Health. Both companies offer telehealth access to these medications, but the details matter—especially when you're making a decision about your health and your budget. Let's walk through what really sets these services apart, so you can choose the option that fits your life.

Understanding the Basics: What Both Companies Offer

Henry Meds and Ozari Health are both telehealth platforms that connect you with licensed physicians who can prescribe GLP-1 medications for weight management. These are the same class of medications you've heard about—Semaglutide (the active ingredient in Wegovy and Ozempic) and Tirzepatide (the active ingredient in Zepbound and Mounjaro).

Both companies provide compounded versions of these medications, which means they're prepared by specialized pharmacies rather than being brand-name products. This is what makes them more affordable while still containing the same active ingredients your body needs.

You'll get a virtual consultation, a prescription if appropriate, and medication delivered to your home. That's where the similarities end, though. The differences in pricing structure, medication access, and ongoing support can significantly impact your experience.

Pricing: Breaking Down the Real Costs

This is often the first question—and it matters. Henry Meds typically starts around $297 per month for Semaglutide, though pricing can vary based on dosage and promotions. Their Tirzepatide pricing tends to be higher, often in the $350-$450 range depending on your dose.

Ozari Health starts at $99 per month for compounded Semaglutide, with Tirzepatide options also available at competitive rates. This lower entry point makes GLP-1 therapy accessible to more people who might otherwise struggle with the cost.

Here's what's important to understand: the cheapest option isn't always the best value. You need to consider what's included in that monthly price. Does it cover your medical consultations? What about dosage adjustments? How often do you need to pay additional fees?

Hidden Costs and What's Included

With Henry Meds, your monthly medication cost typically includes the prescription itself, but you'll want to clarify whether ongoing consultations or dosage adjustments incur additional charges. Some patients report surprise fees when needing to change their dose or speak with a provider between scheduled check-ins.

Ozari's pricing is designed to be transparent. Your monthly cost includes your medication, access to the care team for questions and adjustments, and ongoing medical oversight. There aren't surprise consultation fees when you need to adjust your dose or have concerns about side effects—which, let's be honest, is pretty common when you're starting a GLP-1 medication.

Access: How Quickly Can You Start?

Getting started matters, especially when you've made the decision to invest in your health. Both platforms offer relatively quick initial consultations—usually within a few days of signing up.

Henry Meds has a straightforward intake process with a questionnaire followed by a provider review. If approved, you can typically expect your medication within 1-2 weeks, depending on pharmacy availability and your location.

Ozari Health similarly offers quick intake and approval, with most patients receiving their first shipment within 7-10 days. The real difference shows up in ongoing access—when you need a dose adjustment, have questions about side effects, or need to pause treatment temporarily.

Medication Availability and Supply Chain

Both companies work with FDA-registered compounding pharmacies, but supply chain issues can affect any telehealth provider. It's worth asking about backup pharmacy relationships and what happens if there's a supply interruption. Ozari works with multiple pharmacy partners to minimize the risk of treatment interruptions—something that's increasingly important as demand for these medications continues to grow.

Clinical Support: What Happens After You Start

This is where your experience really diverges. Starting a GLP-1 medication is just the beginning. You'll likely need dose adjustments. You might experience side effects. You'll have questions about how to manage symptoms or what to expect as you progress.

Henry Meds provides medical oversight, but the level of ongoing support can vary. Some patients report difficulty reaching providers between scheduled check-ins or delays in getting responses to important questions about side effects or dosing concerns.

Ozari Health was built with a different model in mind. The care team includes physicians who specialize in metabolic health and GLP-1 therapy—not just general practitioners who occasionally prescribe these medications. You're not just getting a prescription; you're getting ongoing partnership with providers who understand the nuances of how these medications work in different bodies.

The Titration Process

Titration—gradually increasing your dose—is crucial for minimizing side effects and finding your optimal therapeutic dose. This isn't a one-size-fits-all process. Some people need to increase more slowly. Others may find their sweet spot at a lower dose than expected.

Ozari's physicians work with you to personalize this process based on your response, side effects, and weight loss progress. This isn't a rigid protocol where everyone increases by the same amount on the same schedule. It's individualized medicine, which is what actually works for sustainable weight loss.

For Women: Considerations That Matter

Women often experience GLP-1 medications differently than men, particularly around hormonal changes. If you're perimenopausal or menopausal, your response to these medications might fluctuate with your cycle or hormonal state. You may also need more careful management of side effects like nausea, which some women report experiencing more intensely.

Having a care team that understands these gender-specific considerations—and doesn't dismiss them—makes a real difference in your experience and outcomes. Ask potential providers how they adjust protocols for women at different life stages.

For Men: What You Should Know

Men often lose weight more quickly on GLP-1 medications initially, which can be encouraging but also requires careful monitoring to ensure adequate nutrition and muscle preservation. If you're combining these medications with strength training, you'll want a provider who understands how to support muscle maintenance while in a caloric deficit.

Men also tend to report fewer gastrointestinal side effects on average, but when they do occur, they may be less likely to report them. Having a provider you feel comfortable communicating with openly matters for getting the support you need.

Making Your Decision: What Matters Most

Choosing between Henry Meds and Ozari ultimately depends on what you value most. If your primary concern is finding any access point to these medications and you're comfortable being more self-directed in your care, either option could work.

If you want a true partnership with physicians who specialize in this area, transparent pricing without surprise fees, and ongoing support that doesn't require fighting for attention, Ozari's model is designed specifically for that experience.

Consider these questions as you decide: How much support will you realistically need? What's your budget not just for the first month, but for 6-12 months of treatment? How important is it to have responsive access to your care team? Do you have any complicating factors like other medications or health conditions that might require more personalized oversight?

Ready to Start Your Journey?

At Ozari Health, we offer compounded Semaglutide and Tirzepatide as low as $99/month, prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically reviewed by the Ozari Clinical Care Team — licensed physicians specializing in metabolic health and GLP-1 therapy. Last reviewed: April 25, 2026